DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $41,116,799 | 17.73% |
| Logos Global Management LP | 2,797,501 | $17,624,256 | 2.40% |
| Cormorant Asset Management, LP | 5,150,000 | $32,445,000 | 1.82% |
| RA Capital Management | 2,971,231 | $18,718,755 | 0.35% |
| Avoro Capital Advisors LLC | 3,500,000 | $22,050,000 | 0.30% |
| RTW INVESTMENTS, LP | 1,563,031 | $9,847,095 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 238,200 | $1,501 | 0.15% |
| Virtus ETF Advisers LLC | 20,137 | $126,863 | 0.08% |
| Rock Springs Capital Management LP | 460,391 | $2,900,463 | 0.07% |
| Corton Capital Inc. | 17,323 | $109,135 | 0.05% |